MICHAEL JOHN KASTER

Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease GREENVILLE, SC NPI 1891180980

General Payments — all program years on this page

$11,042.52

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 80
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $858.47 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $858.4719

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $265.524
2020 $195.433
2021 $413.3718
2022 $3,262.7412
2023 $6,046.9924
2024 $858.4719

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077584606 Ethicon Inc. $127.35 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077584610 Ethicon Inc. $57.78 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087848391 Pulmonx Corporation $36.40 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087848393 Pulmonx Corporation $38.00 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087848395 Pulmonx Corporation $117.25 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104379797 AstraZeneca Pharmaceuticals LP $19.47 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104530290 AstraZeneca Pharmaceuticals LP $25.62 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104761330 AstraZeneca Pharmaceuticals LP $18.79 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105814547 AstraZeneca Pharmaceuticals LP $17.54 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114082813 Regeneron Healthcare Solutions, Inc. $14.68 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116184308 GlaxoSmithKline, LLC. $14.57 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116315108 GlaxoSmithKline, LLC. $17.48 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116633281 GlaxoSmithKline, LLC. $17.76 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118216829 Boehringer Ingelheim Pharmaceuticals, Inc. $22.71 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137596300 Takeda Pharmaceuticals U.S.A., Inc. $31.38 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141735255 Merck Sharp & Dohme LLC $32.10 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142297305 ABIOMED $42.04 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143700336 Noah Medical Corporation $35.18 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144504204 Galvanize Therapeutics, Inc $172.37 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.